<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Behav Brain Funct</journal-id><journal-title>Behavioral and Brain Functions</journal-title><issn pub-type="epub">1744-9081</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1744-9081-1-25</article-id><article-id pub-id-type="pmid">16375773</article-id><article-id pub-id-type="doi">10.1186/1744-9081-1-25</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Cystathionine &#x003b2;-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Dutta</surname><given-names>Samikshan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mikpal2000@yahoo.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Sinha</surname><given-names>Swagata</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mvkendra@cal2.vsnl.net.in</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Chattopadhyay</surname><given-names>Anindita</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>anindita65@yahoo.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Gangopadhyay</surname><given-names>Prasanta Kumar</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>pkganguly100@yahoo.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Mukhopadhyay</surname><given-names>Jotideb</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>drmadhumita@dataone.in</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Singh</surname><given-names>Manoranjan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>manosingh63@yahoo.com</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Mukhopadhyay</surname><given-names>Kanchan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kanchanmvk@yahoo.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Manovikas Biomedical Research and Diagnostic Centre, E.M. Bypass, Kolkata, India</aff><aff id="I2"><label>2</label>Chittaranjan National Medical College, Kolkata, India</aff><aff id="I3"><label>3</label>Department of Medicine, IPGMER, S.S.K.M Hospital, Kolkata, India</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2005</year></pub-date><volume>1</volume><fpage>25</fpage><lpage>25</lpage><ext-link ext-link-type="uri" xlink:href="http://www.behavioralandbrainfunctions.com/content/1/1/25"/><history><date date-type="received"><day>16</day><month>11</month><year>2005</year></date><date date-type="accepted"><day>26</day><month>12</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Dutta et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Dutta et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Dutta Samikshan mikpal2000@yahoo.com </dc:author><dc:title> Cystathionine &#x003b2;-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>Behavioral and Brain Functions 1(1): 25-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1744-9081(2005)1:1&#x0003c;25&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1744-9081</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Cystathionine &#x003b2;-synthase (CBS) mediates conversion of homocysteine to cystathionine and deficiency in enzyme activity may lead to hyperhomocysteinemia/homocystinuria, which are often associated with mental retardation (MR). A large number of polymorphisms have been reported in the <italic>CBS </italic>gene, some of which impair its activity and among these, a T833C polymorphism in <italic>cis </italic>with a 68 bp insertion at 844 in the exon 8 is found to be associated with mild hyperhomocysteinemia in different ethnic groups.</p></sec><sec sec-type="methods"><title>Methods</title><p>The present study is aimed at investigating the association between T833C/844ins68 polymorphism and MR. One hundred and ninety MR cases were recruited after psychometric evaluation. Hundred and thirty-eight control subjects, two hundred and sixty-seven parents of MR probands and thirty cardiovascular disorder (CVD) patients were included for comparison. Peripheral blood was collected after obtaining informed written consent. The T833C/844ins68 polymorphism was investigated by PCR amplification of genomic DNA and restriction fragment length polymorphism analysis, followed by statistical analysis.</p></sec><sec><title>Results</title><p>The genotypic distribution of the polymorphism was within the Hardy-Weinberg equilibrium. A slightly increased genotypic frequency was observed in the Indian control population as compared to other Asian populations. Both haplotype-based haplotype relative risk analysis and transmission disequilibrium test reveled lack of association of the T833C/844ins68 polymorphism with MR; nevertheless, the relative risk calculated was higher (&#x0003e;1) and in a limited number of informative MR families, preferential transmission of the double mutant from heterozygous mothers to the MR probands was noticed (&#x003c7;<sup>2 </sup>= 4.00, <italic>P </italic>&#x0003c; 0.05).</p></sec><sec><title>Conclusion</title><p>This is the first molecular genetic study of <italic>CBS </italic>gene dealing with T833C/844ins68 double mutation in MR subjects. Our preliminary data indicate lack of association between T833C/844ins68 polymorphism with MR. However, higher relative risk and biased transmission of the double mutation from heterozygous mothers to MR probands are indicative of a risk of association between this polymorphism with mental retardation.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Cystathionine &#x003b2;-synthase (CBS) catalyzes the condensation of serine and homocysteine to form cystathionine and abnormality in CBS activity is manifested in two major clinical conditions, viz. hyperhomocysteinemia and homocystinuria. Insufficiency in CBS activity may lead to hyperhomocysteinemia [<xref ref-type="bibr" rid="B1">1</xref>], which is considered to be an independent risk factor for arteriosclerosis [<xref ref-type="bibr" rid="B2">2</xref>]. In addition to that, since homocysteine is vasculotoxic as well as neurotoxic, hyperhomocysteinemia predisposes to cardiovascular disorder (CVD) and cognitive dysfunction [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. On the other hand, gross deficiency in CBS activity is associated with homocystinuria, an inborn recessive metabolic disorder [<xref ref-type="bibr" rid="B4">4</xref>]. The major pathologic abnormalities associated with homocystinuria include thromboembolism, ectopia lentis, osteoporosis, mental retardation (MR) and other neurological and psychiatric abnormalities [<xref ref-type="bibr" rid="B4">4</xref>]. The neurological malfunctioning can be ascribed to the oxidation of excess homocysteine to homocysteic acid, which interacts with the N-methyl-D-aspartate receptor, causing excessive calcium influx and free radical production, thereby leading to neurotoxicity [<xref ref-type="bibr" rid="B5">5</xref>]. In addition, MR associated with B12 and folate deficiency could be attributed to the neurotoxic effects of homocysteine since B12 and folate act as co-factors in the homocysteine to methionine remethylation pathway.</p><p>The human <italic>CBS </italic>gene, located at 21q22.3 [<xref ref-type="bibr" rid="B6">6</xref>], is known to have a large number of mutations, the majority of which are missense in nature [<xref ref-type="bibr" rid="B7">7</xref>]. Three different nonsense mutants, as well as some insertion, deletion and splice variants have also been identified, some of which are polymorphic in nature. A transition mutation, T833C generating a BsrI restriction site [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>] is known to segregate in <italic>cis </italic>with 844ins68 mutation in exon 8 [<xref ref-type="bibr" rid="B10">10</xref>] and is reported to be associated with premature occlusive arterial disease [<xref ref-type="bibr" rid="B11">11</xref>]. Ethnic heterogeneity of 844ins68 polymorphism is highly prevalent in African, European and North American populations [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p><p>Since the T833C/844ins68 double mutation was not detected by Franco et al. [<xref ref-type="bibr" rid="B13">13</xref>] and Pepe et al. [<xref ref-type="bibr" rid="B14">14</xref>] in their studies on some Asian populations (Japanese, Tharu, Chinese and Indonesian), this allele has been projected by Pepe et al. [<xref ref-type="bibr" rid="B14">14</xref>] as a reliable anthropogenetic marker for discriminating between two major human groups &#x02013; Africans and Asians. Later on, the 844ins68 variant was observed in Han Chinese population with a very low frequency [<xref ref-type="bibr" rid="B15">15</xref>]; however, the T833C polymorphism was not studied. In India, study on T833C mutation revealed 4.76% and 9.99% heterozygotes in control and coronary heart disease patients respectively [<xref ref-type="bibr" rid="B16">16</xref>]. In the present study, we have looked into the frequency of the double mutant in control population. We have also investigated the occurrence of this double mutant in MR individuals and a small subset of CVD patients, since hyperhomocysteinemia/homocystinuria is often associated with MR as well as CVD [<xref ref-type="bibr" rid="B4">4</xref>]. Familial transmission pattern of the double mutation was analyzed, by haplotype-based haplotype relative risk analysis (HHRR) and transmission disequilibrium test (TDT), using heterozygous parents only.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study design</title><p>Our study population consisted of 138 healthy control individuals, 30 CVD patients (average age 53.5 yrs) and 190 MR children (age range 6&#x02013;8 yrs) along with their parents. The cardiologist (J.M) involved in the study helped in collection of samples from CVD patients. MR cases were selected from the Outpatient Department of Manovikas Kendra Rehabilitation and Research Institute, Kolkata and diagnosed by mental health professionals (child psychiatrist, child psychologist and neurologist) according to the DSM &#x02013; IV [<xref ref-type="bibr" rid="B17">17</xref>] followed by an IQ assessment with Wechsler Intelligence Scale for Children [<xref ref-type="bibr" rid="B18">18</xref>]. Both patients and controls were from different parts of India and belonged to no particular ethnic group. Peripheral blood was collected in EDTA, after obtaining informed written consent from control individuals, CVD patients, and parents of MR probands. Genomic DNA was isolated by standard high salt precipitation method [<xref ref-type="bibr" rid="B19">19</xref>]. The Human Ethical Committee of the Institute approved the study protocol.</p></sec><sec><title>PCR amplification</title><p>The primer sequence to amplify the 844ins68 polymorphism in the exon 8 and flanking intron 7 of the <italic>CBS </italic>gene were: sense, 5'-GTTGTTAACGGCGGTATTGG-3', and antisense, 5'- GTTGTCTGCTCCGTCTGGTT-3'. PCR amplification was carried out using Perkin Elmer thermal cycler (Gene Amp #2400) in a reaction volume of 20 &#x003bc;L containing 75&#x02013;100 ng of genomic DNA, 20 pmoles of each primer, 1.0 U Taq polymerase (Bangalore Genei, India), 200 &#x003bc;M dNTP mix, 0.001% gelatin and 10 mM Tris buffer (Bangalore Genei, India) with 50 mM KCl and 1.0 mM MgCl<sub>2</sub>. After an initial denaturation at 95&#x000b0;C for 3 min, amplification was performed at: 35 cycles of denaturation at 94&#x000b0;C for 45 sec, annealing at 58&#x000b0;C for 40 sec and extension at 72&#x000b0;C for 40 sec, followed by a final extension for 5 min at 72&#x000b0;C. PCR products were separated by 12% polyacrylamide gel electrophoresis at 200V for 3 hrs, stained with ethidium bromide and documented in a Gel Doc&#x02122; EQ (BIO-RAD). The wild type allele gave 171 bp fragment (A1), and insertion variant gave 239 bp fragment (A2) (Fig. <xref ref-type="fig" rid="F1">1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Representation of double mutation in exon 8 of <italic>CBS </italic>gene: </bold>lane 1 = homozygous genotype without insertion, lane 2 = heterozygous genotype with 68 bp insertion, lane 3 = &#x003c6;X174 HaeIII digest showing bands at 310, 281, 234,194 and 118 respectively, lane 4 = BsrI digestion of heterozygous PCR product (of lane 2), showing complete digestion of the higher allele of 239 bp into 130 bp and 109 bp.</p></caption><graphic xlink:href="1744-9081-1-25-1"/></fig></sec><sec><title>Restriction fragment length polymorphism (RFLP) analysis</title><p>BsrI digestion was carried out for all samples to detect T833C mutation [<xref ref-type="bibr" rid="B9">9</xref>]. PCR products (3 &#x003bc;L) were digested at 65&#x000b0;C for 3 hrs. in a final reaction volume of 25 &#x003bc;L, containing 1 U of BsrI (New England Biolabs; NEB) and NEB Buffer 4. Since this point mutation occurs in <italic>cis </italic>with 844ins68, only the higher allele of 239 bp (A2) was cleaved by BsrI yielding two fragments of 130 bp and 109 bp respectively (Fig <xref ref-type="fig" rid="F1">1</xref>); wild type allele of 171 bp (A1), however, remained undigested.</p></sec><sec><title>Statistical analysis</title><p>Frequency of the T833C/844ins68 polymorphism in the control population and patients was calculated for the Hardy-Weinberg equilibrium. Haplotype-based haplotype relative risk (HHRR) analysis [<xref ref-type="bibr" rid="B20">20</xref>] as well as transmission disequilibrium test (TDT) [<xref ref-type="bibr" rid="B21">21</xref>] was used to ascertain association between MR and transmission of the double mutation. For TDT, trios with at least one parent having heterozygous genotype were selected.</p></sec></sec><sec><title>Results</title><p>Distribution of 844ins68 heterozygote in various control populations studied worldwide is presented in Table <xref ref-type="table" rid="T1">I</xref>. It was reported earlier that this variant is absent in the Asian population [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Later studies involving larger sample size revealed the occurrence of 844ins68 variant in the Chinese population [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B25">25</xref>] with a very low frequency of heterozygote as compared to the European and African subjects. We have analyzed the 844ins68 variant in association with the T833C mutation and our data showed a higher rate of occurrence of the double mutant in the Indian control population (7.97%) as compared to the Chinese population.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Global variation of <italic>CBS </italic>844ins68 polymorphism in control individuals.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Population</td><td align="center">2n</td><td align="center">Heterozygosity (%)</td><td align="center">Reference</td></tr></thead><tbody><tr><td align="center">US (mixed)</td><td align="center">144</td><td align="center">11.7</td><td align="center">Tsai et al. [9]</td></tr><tr><td align="center">Dutch</td><td align="center">214</td><td align="center">14</td><td align="center">Kluijtmans et al. [22]</td></tr><tr><td align="center">Japanese</td><td align="center">80</td><td align="center">0.00</td><td align="center">Franco et al. [13]</td></tr><tr><td align="center">Chinese</td><td align="center">26</td><td align="center">0.00</td><td align="center">Pepe et al. [14]</td></tr><tr><td align="center">Indonesian</td><td align="center">98</td><td align="center">0.00</td><td align="center">Pepe et al. [14]</td></tr><tr><td align="center">Ethiopian</td><td align="center">108</td><td align="center">11.11</td><td align="center">Pepe et al. [14]</td></tr><tr><td align="center">Spanish</td><td align="center">54</td><td align="center">25.9</td><td align="center">Pepe et al. [14]</td></tr><tr><td align="center">Sub-Saharan African</td><td align="center">180</td><td align="center">66.66</td><td align="center">Pepe et al. [14]</td></tr><tr><td align="center">German</td><td align="center">400</td><td align="center">1.5</td><td align="center">Linnebank et al. [23]</td></tr><tr><td align="center">Chinese (Southern China)</td><td align="center">200</td><td align="center">5</td><td align="center">Zhang &#x00026; Dai [15]</td></tr><tr><td align="center">Italian</td><td align="center">820</td><td align="center">13.7</td><td align="center">Grossmann et al. [24]</td></tr><tr><td align="center">Chinese (Northern China)</td><td align="center">248</td><td align="center">2.97</td><td align="center">Li et al. [25]</td></tr><tr><td align="center">Indian</td><td align="center">276</td><td align="center">7.97</td><td align="center">Present study</td></tr></tbody></table><table-wrap-foot><p>2n = No. of chromosomes</p></table-wrap-foot></table-wrap><p>Frequency of the double mutant allele in different types of subjects is presented in Table <xref ref-type="table" rid="T2">II</xref>. Eleven out of 138 control individuals (n = 276) appeared heterozygous for the mutation. On the contrary, only one person out of 30 CVD patients showed heterozygous genotype. In the MR group, 12 out of 190 MR probands showed presence of the polymorphism and no significant deviation in allele frequencies was noted in the MR probands and their parents (Table <xref ref-type="table" rid="T2">II</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Distribution of <italic>CBS </italic>T833C/844ins68 polymorphism in different groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Groups</td><td align="center">No of chromosome</td><td align="center">No of mutants</td><td align="left">Mutant allele frequency &#x000b1; SE</td></tr></thead><tbody><tr><td align="center">Control</td><td align="center">276</td><td align="center">11</td><td align="center">0.0398 &#x000b1; 0.0117</td></tr><tr><td align="center">CVD Patients</td><td align="center">60</td><td align="center">1</td><td align="center">0.0166 &#x000b1; 0.0166</td></tr><tr><td align="center">MR probands</td><td align="center">380</td><td align="center">12</td><td align="center">0.0316 &#x000b1; 0.0089</td></tr><tr><td align="center">Parents of probands</td><td align="center">534</td><td align="center">15</td><td align="center">0.028 &#x000b1; 0.0071</td></tr></tbody></table></table-wrap><p>HHRR analysis for the T833C/844ins68 polymorphism showed lack of significant association between MR and transmission of the double mutant (&#x003c7;<sup>2 </sup>= 1.714, <italic>P </italic>= 0.1905) (Table <xref ref-type="table" rid="T3">III</xref>). TDT analysis also revealed lack of association between the T833C/844ins68 polymorphism and MR (&#x003c7;<sup>2 </sup>= 1.00, <italic>P </italic>= 0.3173) (Table <xref ref-type="table" rid="T3">III</xref>). However, transmission from the mother (Table <xref ref-type="table" rid="T4">IV</xref>), heterozygous for the alleles, revealed that the A2 allele was preferentially transmitted to the MR probands (&#x003c7;<sup>2 </sup>= 4.00, <italic>P </italic>= 0.0455), while no significant contribution of the paternal allele was noticed (data not presented).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>HHRR and TDT Analysis for the <italic>CBS </italic>T833C/844ins68 polymorphism in nuclear families with MR probands.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><italic>Allele</italic></td><td align="center"><italic>Transmitted</italic></td><td align="center"><italic>Non-transmitted</italic></td><td align="center">&#x003c7;<sup>2</sup></td><td align="center"><italic>P value</italic></td><td align="left">Relative risk (RR)</td></tr></thead><tbody><tr><td align="center">HHRR analysis</td><td align="center">1</td><td align="center">259</td><td align="center">264</td><td align="center">1.714</td><td align="center">0.1905</td><td align="left">1.346</td></tr><tr><td></td><td align="center">2</td><td align="center">10</td><td align="center">5</td><td></td><td></td><td></td></tr><tr><td align="center">TDT analysis</td><td align="center">1</td><td align="center">3</td><td align="center">6</td><td align="center">1.00</td><td align="center">0.3173</td><td></td></tr><tr><td></td><td align="center">2</td><td align="center">6</td><td align="center">3</td><td></td><td></td><td></td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Transmission pattern of <italic>CBS </italic>T833C/844ins68 from mother to MR proband.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">Allele</td><td align="center">Transmitted</td><td align="center">Non-transmitted</td><td align="center">&#x003c7;<sup>2</sup></td><td align="center"><italic>P </italic>value</td></tr></thead><tbody><tr><td align="center">HHRR analysis (all mothers)</td><td align="center">1</td><td align="center">176</td><td align="center">180</td><td align="center">2.0449</td><td align="center">0.1527</td></tr><tr><td></td><td align="center">2</td><td align="center">6</td><td align="center">2</td><td></td><td></td></tr><tr><td align="center">HHRR analysis (heterozygous mothers only)</td><td align="center">1</td><td align="center">2</td><td align="center">6</td><td align="center">4.00</td><td align="center">0.0455</td></tr><tr><td></td><td align="center">2</td><td align="center">6</td><td align="center">2</td><td></td><td></td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>The present finding of 11 out of 138 Indian control individuals with the T833C/844ins68 polymorphism reveal a higher percentage of heterozygotes (7.97%) as compared to the Chinese control population (Table <xref ref-type="table" rid="T1">I</xref>); but, this value is significantly lower than those quoted for Sub-Saharan population [<xref ref-type="bibr" rid="B14">14</xref>]. Two earlier independent studies on Japanese and other Asian populations failed to detect the mutated allele [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>] and this led to the proposal that this unique double mutation could be used as a reliable anthropogenetic marker for differentiating Asians and Africans. However, the validity of the proposal is questioned by subsequent findings of the 844ins68 polymorphism in different Chinese populations [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B25">25</xref>] and T833C transition mutation in Indian population [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The present study clearly demonstrates that the T833C/844ins68 polymorphism may not be suitable as an anthropogenetic marker for differentiating Asians and Africans.</p><p>Among Indians, presence of T833C heterozygote has been reported in 1 out of 21 (4.76%) [<xref ref-type="bibr" rid="B16">16</xref>] and 3 out of 100 (3%) [<xref ref-type="bibr" rid="B26">26</xref>] control individuals. However, in both studies the association of 844ins68 mutation with the T833C transition mutation has not been mentioned, while in the present investigation we have observed invariable segregation of these two mutations in <italic>cis</italic>, which is consistent with earlier observations [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Hyperhomocysteinemia is hypothesized as an independent risk factor for CVD [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B27">27</xref>] and the 844ins68 variant was previously reported to be associated with premature occlusive arterial disease [<xref ref-type="bibr" rid="B11">11</xref>]. A recent article on Chinese congenital heart disease (CHD) patients have shown that the 844ins68 could be a risk factor for CHD, and the insertion especially in mothers could increase the risk in offspring [<xref ref-type="bibr" rid="B25">25</xref>]. On the other hand, the findings of Zhang and Dai [<xref ref-type="bibr" rid="B15">15</xref>] on adult Chinese patients have suggested that the 844ins68 could provide protection to vascular thromboembolic disease. The mutant allele frequencies among the Indian controls and the CVD patients are 0.0398 and 0.0166 respectively (Table <xref ref-type="table" rid="T2">II</xref>) and no association was observed between T833C/844ins68 polymorphism and CVD. Heterozygous T833C/844ins68 alleles were observed at higher percentage in Indian CVD patients (3.33%) as compared to Chinese ischemic patients (~1%). The lower value of 3.33% for CVD patients as compared to that of the control (7.97%) seems to support the idea of a possible protective role of the double mutation to vascular thromboembolic disease, as proposed by Zhang and Dai [<xref ref-type="bibr" rid="B15">15</xref>]; however, such a conclusion is not called for due to the relatively small CVD sample size in the present study.</p><p>While the T833C mutation results in Ile278Thr change in the mutant protein, in the case of T833C/844ins68, the 68 bp insertion results in an alternative splice site generating mostly wild type mRNA with traces of another transcript, detectable only in the nucleus [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. This accounts for the rescue of the transition mutation at 278 in the case of the double mutant [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. However, these observations cannot account for the conflicting reports on the association between cardiovascular disease in different ethnic populations and the mutant allele [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Case control studies showed that this double mutation might be a neutral polymorphism in the <italic>CBS </italic>gene and splicing of the intron 7 eliminates the mutant allele carrying the T833C [<xref ref-type="bibr" rid="B22">22</xref>]. On the other hand, in Northern Europe, the T833C mutation is common in patients presenting clinically with homocystinuria and is associated with a B6-responsive phenotype [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B28">28</xref>].</p><p>The <italic>CBS </italic>T833C/844ins68 polymorphism has been reported in homozygous condition, with a very low frequency, from American black artheroslerosis patients [<xref ref-type="bibr" rid="B9">9</xref>]. We have failed to observe any subject homozygous for the mutation in our study group, which possibly points towards the deleterious effect of this mutation in homozygous condition.</p><p>The present finding of preferential transmission of T833C/844ins68 polymorphism to the MR proband from the heterozygous mother is the first evidence of any association of <italic>CBS </italic>gene with MR, although the association of hyperhomocysteinemia/homocystinuria with psychiatric manifestations including MR is well established [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Among different markers for cobalamine/folate status, plasma homocysteine showed the best association with aging related neuropsychiatric dysfunction [<xref ref-type="bibr" rid="B31">31</xref>] and an earlier investigation revealed that the CBS 844ins68 allele frequency was lower in children with high IQ as compared to those with average IQ [<xref ref-type="bibr" rid="B32">32</xref>]. In the present investigation, though the HHRR and TDT analysis failed to show any significant transmission of the mutant allele to the MR probands (&#x003c7;<sup>2 </sup>= 1.714 and 1.00 respectively), the relative risk (RR = 1.346) calculated showed a risk of MR associated with transmission of the mutant allele. The preferential transmission of T833C/844ins68 polymorphism from the heterozygous mother to the MR proband (&#x003c7;<sup>2 </sup>= 4.00, <italic>P </italic>= 0.0455) also supports the above possibility.</p></sec><sec><title>Conclusion</title><p>This is the first report on <italic>CBS </italic>T833C/844ins68 polymorphism in association with MR and to the best of our knowledge, this is also the first information on the occurrence of the <italic>CBS </italic>double mutation in the Indian population. Our preliminary data indicate lack of significant association between T833C/844ins68 polymorphism with MR; however, the relative risk calculated and the preferential transmission of the double mutation from informative mothers to MR probands do suggest a risk of association of this polymorphism with MR and warrants further investigation.</p></sec><sec><title>List of Abbreviations used</title><p>MR (Mental retardation), CBS (Cystathionine &#x003b2;-synthase), CVD (cardiovascular disorder), HHRR (haplotype-based haplotype relative risk), TDT (transmission disequilibrium test), CHD (congenital heart disease).</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Contributors</title><p>SD (JRF, DBT Grant) was responsible for acquisition of data and analysis and drafting the article. SS performed psychometric analysis and clinical diagnosis, intellectual contribution. AC helped in psychological evaluation and IQ determination. PKG was responsible for neurological investigations and intellectual contribution. JG diagnosed the CVD cases. MS revised the manuscript critically. KM was responsible for concept and study design, interpretation of data and revising the article critically. Final manuscript was approved by all authors.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Authors are thankful to the families who have participated in the study. This work was partly sponsored by a grant from the Department of Biotechnology, Government of India; Grant No. <underline>BT/PR4269/SPD/11/478/2003.</underline></p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Daly</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>K</given-names></name><name><surname>Naughten</surname><given-names>E</given-names></name><name><surname>Cahalane</surname><given-names>S</given-names></name><name><surname>Fowler</surname><given-names>B</given-names></name><name><surname>Graham</surname><given-names>I</given-names></name></person-group><article-title>Homocysteinemia: A risk factor for vascular disease</article-title><source>N Eng J Med</source><year>1991</year><volume>325</volume><fpage>967</fpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boushey</surname><given-names>CJ</given-names></name><name><surname>Beresford</surname><given-names>SAA</given-names></name><name><surname>Omenn</surname><given-names>GS</given-names></name><name><surname>Motulsky</surname><given-names>AG</given-names></name></person-group><article-title>A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes</article-title><source>J Am Med Assoc</source><year>1995</year><volume>274</volume><fpage>1049</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1001/jama.274.13.1049</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>NA</given-names></name><name><surname>Neill</surname><given-names>DW</given-names></name></person-group><article-title>Metabolic abnormalities detected in a survey of mentally backward individuals in North Ireland</article-title><source>Arch Dis Child</source><year>1962</year><volume>37</volume><fpage>505</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">14018926</pub-id></citation></ref><ref id="B4"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Mudd</surname><given-names>SH</given-names></name><name><surname>Levy</surname><given-names>HL</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B</surname></name></person-group><article-title>From Disorders of transulfuration</article-title><source>The metabolic and molecular bases of inherited disease</source><year>2001</year><edition>8</edition><publisher-name>New York: McGraw-Hill</publisher-name><fpage>2007</fpage><lpage>2056</lpage></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>SA</given-names></name><name><surname>Kim</surname><given-names>WK</given-names></name><name><surname>Choi</surname><given-names>YB</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>D'Emilia</surname><given-names>DM</given-names></name><name><surname>Rayudu</surname><given-names>PV</given-names></name><name><surname>Arnelle</surname><given-names>DR</given-names></name><name><surname>Stamler</surname><given-names>JS</given-names></name></person-group><article-title>Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor</article-title><source>Proc Natl Acad Sci</source><year>1997</year><volume>94</volume><fpage>5923</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">9159176</pub-id><pub-id pub-id-type="doi">10.1073/pnas.94.11.5923</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munke</surname><given-names>M</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name><name><surname>Ohura</surname><given-names>T</given-names></name><name><surname>Francke</surname><given-names>U</given-names></name></person-group><article-title>The gene for cystathionine &#x003b2;-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17</article-title><source>Am J Hum Genet</source><year>1988</year><volume>42</volume><fpage>550</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">2894761</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname><given-names>JP</given-names></name><name><surname>Oliveriusova</surname><given-names>J</given-names></name><name><surname>Sokolova</surname><given-names>J</given-names></name><name><surname>Kraus</surname><given-names>E</given-names></name><name><surname>Vlcek</surname><given-names>C</given-names></name><name><surname>de Franchis</surname><given-names>R</given-names></name><name><surname>Maclean</surname><given-names>KN</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Bukovska</surname><given-names>G</given-names></name><name><surname>Patterson</surname><given-names>D</given-names></name><name><surname>Paces</surname><given-names>V</given-names></name><name><surname>Ansorge</surname><given-names>W</given-names></name><name><surname>Kozich</surname><given-names>V</given-names></name></person-group><article-title>The human cystathionine &#x003b2;-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms</article-title><source>Genomics</source><year>1998</year><volume>52</volume><fpage>312</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9790750</pub-id><pub-id pub-id-type="doi">10.1006/geno.1998.5437</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozich</surname><given-names>V</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name></person-group><article-title>Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine &#x003b2;-synthase deficiency</article-title><source>Hum Mutat</source><year>1992</year><volume>1</volume><fpage>113</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">1301198</pub-id><pub-id pub-id-type="doi">10.1002/humu.1380010206</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MY</given-names></name><name><surname>Bignell</surname><given-names>M</given-names></name><name><surname>Schwichtenberg</surname><given-names>K</given-names></name><name><surname>Hanson</surname><given-names>Q</given-names></name></person-group><article-title>High prevalence of a mutation in the cystathionine &#x003b2;-synthase gene</article-title><source>Am J Hum Genet</source><year>1996</year><volume>59</volume><fpage>1262</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">8940271</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebastio</surname><given-names>G</given-names></name><name><surname>Sperandeo</surname><given-names>MP</given-names></name><name><surname>Panico</surname><given-names>M</given-names></name><name><surname>de Franchis</surname><given-names>R</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name><name><surname>Andria</surname><given-names>G</given-names></name></person-group><article-title>The molecular basis of homocystinuria due to cystathionine &#x003b2;-synthase deficiency in Italian families, and report of four novel mutations</article-title><source>Am J Hum Genet</source><year>1995</year><volume>56</volume><fpage>1324</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">7762555</pub-id></citation></ref><ref id="B11"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Orendac</surname><given-names>M</given-names></name><name><surname>Muskova</surname><given-names>B</given-names></name><name><surname>Richterova</surname><given-names>F</given-names></name><name><surname>Zvarova</surname><given-names>J</given-names></name><name><surname>Stefek</surname><given-names>M</given-names></name><name><surname>Zaykova</surname><given-names>E</given-names></name><name><surname>Stribrny</surname><given-names>J</given-names></name><name><surname>Hyanek</surname><given-names>J</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name><name><surname>Kozich</surname><given-names>V</given-names></name></person-group><article-title>Mutation C677T in MTHFR gene and polymorphism 844ins68 in the CBS gene: Risk factor for peripheral arterial occlusive disease?</article-title><source>Neth J Med</source><year>1998</year><fpage>S47</fpage><pub-id pub-id-type="pmid">9883014</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sperandeo</surname><given-names>MP</given-names></name><name><surname>de Franchis</surname><given-names>R</given-names></name><name><surname>Andria</surname><given-names>G</given-names></name><name><surname>Sebastio</surname><given-names>G</given-names></name></person-group><article-title>A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine &#x003b2;-synthase mRNA</article-title><source>Am J Hum Genet</source><year>1996</year><volume>59</volume><fpage>1391</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">8940285</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>RF</given-names></name><name><surname>Elion</surname><given-names>J</given-names></name><name><surname>Lavinha</surname><given-names>J</given-names></name><name><surname>Krishnamoorthy</surname><given-names>R</given-names></name><name><surname>Tavella</surname><given-names>MH</given-names></name><name><surname>Zago</surname><given-names>MA</given-names></name></person-group><article-title>Heterogeneous ethnic distribution of the 844ins68 in the cystathionine &#x003b2;-synthase gene</article-title><source>Hum Hered</source><year>1998</year><volume>48</volume><fpage>338</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">9813456</pub-id><pub-id pub-id-type="doi">10.1159/000022826</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pepe</surname><given-names>G</given-names></name><name><surname>Camacho Vanegas</surname><given-names>O</given-names></name><name><surname>Rickards</surname><given-names>O</given-names></name><name><surname>Giusti</surname><given-names>B</given-names></name><name><surname>Comeglio</surname><given-names>P</given-names></name><name><surname>Brunelli</surname><given-names>T</given-names></name><name><surname>Marcucci</surname><given-names>R</given-names></name><name><surname>Prisco</surname><given-names>D</given-names></name><name><surname>Gensini</surname><given-names>GF</given-names></name><name><surname>Abbate</surname><given-names>R</given-names></name></person-group><article-title>World distribution of the T833C/844INS68 CBS in cis double mutation: a reliable anthropological marker</article-title><source>Hum Genet</source><year>1999</year><volume>104</volume><fpage>126</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">10190322</pub-id><pub-id pub-id-type="doi">10.1007/s004390050924</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Dai</surname><given-names>G</given-names></name></person-group><article-title>Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases</article-title><source>Thromb Res</source><year>2001</year><volume>104</volume><fpage>187</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11672761</pub-id><pub-id pub-id-type="doi">10.1016/S0049-3848(01)00352-8</pub-id></citation></ref><ref id="B16"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>KG</given-names></name><name><surname>Nair</surname><given-names>SR</given-names></name><name><surname>Ashavaid</surname><given-names>TF</given-names></name><name><surname>Dalal</surname><given-names>JJ</given-names></name><name><surname>Eghlim</surname><given-names>FF</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population</article-title><source>J Assoc Physicians India</source><year>2002</year><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12186157</pub-id></citation></ref><ref id="B17"><citation citation-type="other"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and statistical manual of mental disorders, Text Revised: DSM-IV, Washington, DC</source><year>1994</year></citation></ref><ref id="B18"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Wechsler</surname><given-names>D</given-names></name></person-group><source>Wechsler Intelligence Scale for Children-Third Edition: Manual</source><year>1991</year><publisher-name>San Antonio, TX: Psychological Corporation</publisher-name></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SA</given-names></name><name><surname>Dykes</surname><given-names>DD</given-names></name><name><surname>Polesky</surname><given-names>HF</given-names></name></person-group><article-title>A simple salting out procedure for extracting DNA from human nucleated cells</article-title><source>Nucleic Acid Res</source><year>1988</year><volume>16</volume><fpage>1215</fpage><pub-id pub-id-type="pmid">3344216</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terwilliger</surname><given-names>JD</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name></person-group><article-title>A haplotype-based "haplotype relative risk" approach to detecting allelic association</article-title><source>Hum Heredity</source><year>1992</year><volume>42</volume><fpage>337</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">1493912</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spielman</surname><given-names>RS</given-names></name><name><surname>McGinnis</surname><given-names>RE</given-names></name><name><surname>Ewens</surname><given-names>WJ</given-names></name></person-group><article-title>Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)</article-title><source>Am J Hum Genet</source><year>1993</year><volume>52</volume><fpage>506</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">8447318</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kluijtmans</surname><given-names>LAJ</given-names></name><name><surname>Boers</surname><given-names>GHJ</given-names></name><name><surname>Trijbels</surname><given-names>FJM</given-names></name><name><surname>Van Lith-Zanders</surname><given-names>HMA</given-names></name><name><surname>van den Heuvel</surname><given-names>LPWJ</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name></person-group><article-title>A common 844ins68 insertion variant in the cystathionine &#x003b2;-synthase gene</article-title><source>Biochem and Mol Med</source><year>1997</year><volume>62</volume><fpage>23</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9367794</pub-id><pub-id pub-id-type="doi">10.1006/bmme.1997.2623</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linnebank</surname><given-names>M</given-names></name><name><surname>Homberger</surname><given-names>A</given-names></name><name><surname>Junker</surname><given-names>R</given-names></name><name><surname>Nowak-Goettl</surname><given-names>U</given-names></name><name><surname>Harms</surname><given-names>E</given-names></name><name><surname>Koch</surname><given-names>HG</given-names></name></person-group><article-title>High prevalence of the I278T mutation of the human cystathionine &#x003b2;-synthase detected by a novel screening application</article-title><source>Thromb Haemost</source><year>2001</year><volume>85</volume><fpage>986</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">11434706</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grossmann</surname><given-names>R</given-names></name><name><surname>Schwender</surname><given-names>S</given-names></name><name><surname>Geisen</surname><given-names>U</given-names></name><name><surname>Schambeck</surname><given-names>C</given-names></name><name><surname>Merati</surname><given-names>G</given-names></name><name><surname>Walter</surname><given-names>U</given-names></name></person-group><article-title>CBS 844ins68, MTHFR TT677 and EPCR 4031ins23 genotypes in patients with deep-vein thrombosis</article-title><source>Thromb Res</source><year>2002</year><volume>107</volume><fpage>13</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12413583</pub-id><pub-id pub-id-type="doi">10.1016/S0049-3848(02)00187-1</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>WL</given-names></name><name><surname>Dao</surname><given-names>JJ</given-names></name><name><surname>Yan</surname><given-names>LY</given-names></name><name><surname>Li</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>SQ</given-names></name></person-group><article-title>Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease</article-title><source>Beijing Da Xue Xue Bao</source><year>2005</year><volume>37</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15719048</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khare</surname><given-names>A</given-names></name><name><surname>Ghosh</surname><given-names>K</given-names></name><name><surname>Shetty</surname><given-names>S</given-names></name><name><surname>Kulkarni</surname><given-names>B</given-names></name><name><surname>Mohanty</surname><given-names>D</given-names></name></person-group><article-title>Combination of thrombophilia markers in acute myocardial infarction of the young</article-title><source>Ind J Med Sci</source><year>2004</year><volume>58</volume><fpage>381</fpage><lpage>86</lpage></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boers</surname><given-names>GHJ</given-names></name><name><surname>Smals</surname><given-names>AGH</given-names></name><name><surname>Trijbels</surname><given-names>FJM</given-names></name><name><surname>Fowler</surname><given-names>B</given-names></name><name><surname>Bakkeren</surname><given-names>JAJM</given-names></name><name><surname>Schoonderwaldt</surname><given-names>HC</given-names></name><name><surname>Kleijer</surname><given-names>WJ</given-names></name><name><surname>Kloppenborg</surname><given-names>PWC</given-names></name></person-group><article-title>Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease</article-title><source>N Eng J Med</source><year>1985</year><volume>313</volume><fpage>709</fpage><lpage>15</lpage></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaustadnes</surname><given-names>M</given-names></name><name><surname>Ingerslev</surname><given-names>J</given-names></name><name><surname>Rutiger</surname><given-names>N</given-names></name></person-group><article-title>Prevalence of congenital homocystinuria in Denmark</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><fpage>1513</fpage><pub-id pub-id-type="pmid">10328723</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199905133401915</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kluijtmans</surname><given-names>LAJ</given-names></name><name><surname>Boers</surname><given-names>GHJ</given-names></name><name><surname>Kraus</surname><given-names>JP</given-names></name><name><surname>van den Heuvel</surname><given-names>LPWJ</given-names></name><name><surname>Cruysberg</surname><given-names>JRM</given-names></name><name><surname>Trijbels</surname><given-names>FJM</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name></person-group><article-title>The molecular basis of Cystathionine &#x003b2;-Synthase deficiency in Dutch patients with homocystinuria: Effect of CBS genotype on biochemical and clinical phenotype and on response to treatment</article-title><source>Am J Hum Genet</source><year>1999</year><volume>65</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">10364517</pub-id><pub-id pub-id-type="doi">10.1086/302439</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>MH</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>Abbey</surname><given-names>H</given-names></name><name><surname>Pyeritz</surname><given-names>RE</given-names></name></person-group><article-title>Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness</article-title><source>Am J Med Genet</source><year>1987</year><volume>26</volume><fpage>959</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">3591841</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.1320260427</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robins Wahlin</surname><given-names>RB</given-names></name><name><surname>Wahlin</surname><given-names>A</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Backamn</surname><given-names>L</given-names></name></person-group><article-title>The influence of serum vitamin B12 and folate status on cognitive functioning in very old age</article-title><source>Biol Psychol</source><year>2001</year><volume>56</volume><fpage>247</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11399353</pub-id><pub-id pub-id-type="doi">10.1016/S0301-0511(01)00079-5</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barboux</surname><given-names>S</given-names></name><name><surname>Plomin</surname><given-names>R</given-names></name><name><surname>Whitehead</surname><given-names>AS</given-names></name></person-group><article-title>Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function</article-title><source>Neuroreport</source><year>2000</year><volume>11</volume><fpage>1133</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10790895</pub-id></citation></ref></ref-list></back></article> 